The diabetes treatment developer, which counts WL Gore and Johnson & Johnson as investors, has raised a further $27m for its latest round.
Author: Callum Cyrus
Aircall rings up $65m
The call management platform developer has completed a series C round led by DTCP that also featured Swisscom Ventures.
DefinedCrowd attracts series B funding
EDP Ventures and Semapa Next took part in a $50.5m series B round for the AI verification data provider, which counts Amazon, Sony and Mastercard as earlier investors.
MPharma pools investors to raise $17m
Pharmaceuticals distributor MPharma increased its funding to more than $38m in a round that included Dompe Holdings.
GoBear gobbles up $17m
Asia-facing loan and insurance comparison service GoBear has now assembled $97m altogether, having lured existing investor Aegon to its latest round.
CFS sees out $84m series A2 round
Equinor and Eni Next contributed to an $84m round for nuclear fusion technology startup Commonwealth Fusion Systems following a $115m series A last year.
MUFG extends Fundbox’s series C round
Mitsubishi UFJ Financial Group helped the supply chain finance provider increase a round already featuring several corporates to almost $200m.
Inivata nets $25m from NeoGenomics
Cancer diagnostics technology developer Inivata has secured $25m from NeoGenomics to take its total funding to more than $128m.
Platform Science navigates $42m series B
The trucking management software provider secured $42m in a round led by Prologis Ventures that also featured new strategic partner Daimler.
Creditgate24 opens up for Advanon
Swisscom Ventures has exited invoice financing services provider Advanon in an acquisition of undisclosed size by peer Creditgate24.
Oxford Nanopore expands latest round
Illumina and Amgen-backed genomic sequencing technology developer Oxford Nanopore has added $59.6m to a round that now totals $98.1m.
Addi adds $15m to its coffers
Wayra-backed consumer loan provider Addi has boosted its total funding to nearly $32m as it prepares to move into Brazil and Mexico.
CalciMedica collects $15m in series C round
Biogen and GlaxoSmithKline-backed CalciMedica has received series C capital to advance a possible Covid-19 treatment through clinical testing.
Clara Analytics clasps $25m
Clara, an insurance data software provider that counts NewYork-Presbyterian among its investors has added series B funding that will support recruitment.